Navigation Links
Status Conference Scheduled for December in Federal Ethicon Transvaginal Mesh Lawsuit Litigation, More than 10,270 Gynecare Cases Now Filed in Proceeding
Date:10/24/2013

(PRWEB) October 24, 2013

A recent order issued in the federal Ethicon transvaginal mesh lawsuit (http://www.transvaginalmeshlawsuithelp.com/) litigation indicates that its next status conference will be held in December, Bernstein Liebhard LLP reports.

According to a Scheduling Order announced on October 23rd, matters related to lawsuits filed in a proceeding underway in the U.S. District Court, Southern District of West Virginia will be discussed at a joint status conference on December 5th at 12:00 p.m. Recent court documents indicate that 10,270 lawsuits have been filed in the federal proceeding over Gynecare products marketed by the Johnson & Johnson subsidiary, Ethicon Inc. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)

“On a regular basis, our Firm’s lawyers hear from women who allegedly sustained mesh erosion, organ damage and other injuries stemming from Ethicon’s Gynecare pelvic mesh devices. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs in the U.S. Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is currently serving on the Plaintiffs’ Steering Committee in the federal Ethicon vaginal mesh lawsuit litigation. Contact the Firm directly for a free and confidential evaluation of your potential case today.

Transvaginal Mesh Lawsuits

Transvaginal mesh lawsuits filed in the federal Ethicon litigation allege injuries caused by Ethicon’s line of Gynecare pelvic mesh products, which have been associated with mesh erosion, chronic pain, infection and organ damage. According to the lawsuits, these transvaginal mesh complications are often only repairable through corrective surgery to remove the implant. Claims filed against
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
2. Disparities in treatment of children in the emergency department based on their insurance status
3. Plavixs New Generic Status Could Be Boon for Patients
4. Study finds socioeconomic status linked to weight gain and risk of obesity in African-American women
5. Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers
6. Study finds non-disclosure of HIV serostatus common among India female sex workers
7. Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients
8. Childrens health, access to care differ by parents immigrant status
9. Language, immigration status of hispanic caregivers impacted care of children with cancer
10. Socioeconomic status linked to childhood peanut allergy
11. Better Economic Status Tied to Peanut Allergy in Kids: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... 25, 2014 The short film “Color of ... in honor of a true 9/11 hero, Welles Remy Crowther. ... including the 24 hours of Nuremberg International Short Film Festival ... , Actress, screenwriter and director Luciana Lagana plays ... together with her husband, Gregory Graham - Graham ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, LunaDress.co.uk has updated ... dresses and related accessories. Now, all of the models at LunaDress.co.uk ... moment a groom lifts the wedding veil can turn out to ... stunning charm. A wedding veil can always bring surprise to a ... suggestions on how to choose veils for a big day ...
(Date:12/25/2014)... By Dennis Thompson ... -- Researchers could be closing in on a "fountain of ... improve the health of older adults, a new study suggests. ... when given a drug that targets a genetic signaling pathway ... maker Novartis report. The experimental medication, a ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3
... of $39.2 MillionCARLSBAD, Calif., April 30 Genoptix, Inc. ... provider, today reported revenues of $39.2 million for the ... benefit from changes in accounting estimates relating to prior ... over revenues of $22.3 million for the comparable period ...
... risks, agency says, , , THURSDAY, April 30 (HealthDay News) ... injections such as Botox to treat muscle spasms have ... products will now be required to carry boxed warnings, ... Food and Drug Administration announced Thursday. , Most cases ...
... HealthSouth Corporation (NYSE: HLS ) today announced ... Stock Conference on May 12-14, 2009, at the Four Seasons ... and Executive Vice President and Chief Financial Officer John Workman ... ET (7:55 a.m. CT). The presentation will be webcast live ...
... The Missouri House today amended HB21 to allocate at ... grants for maternity homes and pregnancy resource centers in the ... Missouri Senate. , , Americans United for Life ... centers are essential to helping pregnant women in need. ...
... Prospero Group (PRPG) invested into the Private ... split. Prospero Group a leading company in the field ... the new ACTRx Malaria and Dengue fever treatment. Fincor ... Prospero Group enlarges its technology portfolio with ...
... can have significant physical and psychological repercussions that impact ... it can affect their ability to remain employed. Compared ... disabilities, arthritis appears to have a more profound effect ... found that about half of those with severe forms ...
Cached Medicine News:Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 2Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 3Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 4Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 5Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 6Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 7Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 8Health News:Genoptix Reports Strong Growth for the First Quarter of 2009 9Health News:FDA Mandates New Warnings for Botox 2Health News:FDA Mandates New Warnings for Botox 3Health News:Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment 2Health News:Women with arthritis more likely than men to stop working 2Health News:Women with arthritis more likely than men to stop working 3
(Date:12/24/2014)... 23, 2014 In response to urgent requests from the ... Sierra Leone , Direct Relief delivered two 10-bed ... the treatment of local health workers who contract Ebola while ... Ebola care center was constructed for foreign health care workers ... available for local Sierra Leonean health workers. With ...
(Date:12/22/2014)... N.J. , Dec. 22, 2014  CytoSorbents ... marketing its CytoSorb® blood purification technology to help ... patients in 28 countries worldwide, today announced the ... , MD, FACS, as its Senior Vice President ... Dr. Di Russo is ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "US Self-monitoring Blood Glucose Market" report to their ... This market insight focuses on the developments in ... United States . Reimbursement analysis and the effects ... for more than 73 SMBG meters have been performed, ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2
... Aug. 3 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Tuesday, August 10, 2010 at 8:00 a.m. Eastern Time ( 5:00 ... Interested parties may access ... , , ...
... , CLEVELAND , Aug. 3 Researchers ... Washington University School of Medicine in St. Louis, ... use of advanced treatments for cancer patients, will soon become ... system from ViewRay™, Inc. The ViewRay system is designed to ...
Cached Medicine Technology:Onyx Pharmaceuticals to Present at the Canaccord Genuity 30th Annual Growth Conference 2Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System 2Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System 3
... Prostate specific antigen (PSA) is a serine ... within the epithelial cells of the acini and ... serum is 0.1-2.6 ng/mL. Reports have suggested that ... is the must useful tumor markers in diagnosis ...
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite...
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...
... Lancets are designed with Shallow Point Comfort ... gauge needle with its shallow-angled edges act ... penetration without tearing the skin. The unique ... to grip, even for patients with arthritis ...
Medicine Products: